|
1
|
Nathan DM: Diabetes: Advances in diagnosis
and treatment. JAMA. 314:1052–1062. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Stanford KI, Middelbeek RJ and Goodyear
LJ: Exercise effects on white adipose tissue: Beiging and metabolic
adaptations. Diabetes. 64:2361–2368. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chang YY and Chiou WB: Means yield to ends
in weight loss: Focusing on ‘how’ vs ‘why’ aspects of losing weight
can lead to poorer regulation of dietary practices. J Acad Nutr
Diet. 115:1387–1391. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bertz F, Brekke HK, Ellegård L, Rasmussen
KM, Wennergren M and Winkvist A: Diet and exercise weight-loss
trial in lactating overweight and obese women. Am J Clin Nutr.
96:698–705. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Melby CL, Paris HL, Foright RM and Peth J:
Attenuating the biologic drive for weight regain following weight
loss: Must what goes down always go back up? Nutrients. 9:pii:
E468. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bosy-Westphal A, Kahlhöfer J, Lagerpusch
M, Skurk T and Müller MJ: Deep body composition phenotyping during
weight cycling: Relevance to metabolic efficiency and metabolic
risk. Obes Rev. 1 Suppl 16:S36–S44. 2015. View Article : Google Scholar
|
|
7
|
Delahanty LM, Pan Q, Jablonski KA, Aroda
VR, Watson KE, Bray GA, Kahn SE, Florez JC, Perreault L and Franks
PW; Diabetes Prevention Program Research Group, : Effects of weight
loss, weight cycling, and weight loss maintenance on diabetes
incidence and change in cardiometabolic traits in the diabetes
prevention program. Diabetes Care. 37:2738–2745. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Neamat-Allah J, Barrdahl M, Hüsing A,
Katzke VA, Bachlechner U, Steffen A, Kaaks R, Schulze MB, Boeing H
and Kühn T: Weight cycling and the risk of type 2 diabetes in the
EPIC-Germany cohort. Diabetologia. 58:2718–2725. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rhee EJ, Cho JH, Kwon H, Park SE, Park CY,
Oh KW, Park SW and Lee WY: Increased risk of diabetes development
in individuals with weight cycling over 4 years: The kangbuk
samsung health study. Diabetes Res Clin Pract. 139:230–238. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Madigan CD, Pavey T, Daley AJ, Jolly K and
Brown WJ: Is weight cycling associated with adverse health
outcomes? A cohort study. Prev Med. 108:47–52. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rogero MM and Calder PC: Obesity,
inflammation, toll-like receptor 4 and fatty acids. Nutrients.
10:pii: E432. 2018. View Article : Google Scholar
|
|
12
|
Persson PB and Persson Bondke A:
Metabolism, obesity and the metabolic syndrome. Acta Physiol (Oxf).
13:e130962018. View Article : Google Scholar
|
|
13
|
Tarantino G: Gut microbiome,
obesity-related comorbidities, and low-grade chronic inflammation.
J Clin Endocrinol Metab. 99:2343–2346. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ryan DH and Jensen MD: What the new
obesity guidelines will tell us. Curr Opin Endocrinol Diabetes
Obes. 20:429–433. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Boutari C, Perakakis N and Mantzoros CS:
Association of adipokines with development and progression of
nonalcoholic fatty liver disease. Endocrinol Metab (Seoul).
33:33–43. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Andrade-Oliveira V, Câmara NO and
Moraes-Vieira PM: Adipokines as drug targets in diabetes and
underlying disturbances. J Diabetes Res. 2015:6816122015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Wright GL and Peterson JM:
C1q/TNF-related protein 3 (CTRP3) function and regulation. Compr
Physiol. 7:863–878. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Peterson JM, Wei Z and Wong GW:
C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates
hepatic glucose output. J Biol Chem. 285:39691–39701. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yi W, Sun Y, Yuan Y, Lau WB, Zheng Q, Wang
X, Wang Y, Shang X, Gao E, Koch WJ and Ma XL: C1q/tumor necrosis
factor-related protein-3, a newly identified adipokine, is a novel
antiapoptotic, proangiogenic, and cardioprotective molecule in the
ischemic mouse heart. Circulation. 125:3159–3169. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Petersen PS, Wolf RM, Lei X, Peterson JM
and Wong GW: Immunomodulatory roles of CTRP3 in endotoxemia and
metabolic stress. Physiol Rep. 4:e127352016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li X, Jiang L, Yang M, Wu YW, Sun JZ and
Sun SX: CTRP3 improves the insulin sensitivityof 3T3-L1 adipocytes
by inhibiting inflammation and ameliorating insulin signalling
transduction. Endokrynol Pol. 65:252–258. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
List EO, Berryman DE, Wright-Piekarski J,
Jara A, Funk K and Kopchick JJ: The effects of weight cycling on
lifespan in male C57BL/6J mice. Int J Obes (Lond). 37:1088–1094.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li X, Yuan L, Li J, Li H and Cheng S:
Blockade of renin angiotensin system increased resistance to
STZ-induced diabetes in rats with long-term high-fat diet. Exp
Diabetes Res. 2012:6189232012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barbosa-da-Silva S, Fraulob-Aquino JC,
Lopes JR, Mandarim-de-Lacerda CA and Aguila MB: Weight cycling
enhances adipose tissue inflammatory responses in male mice. PLoS
One. 7:e398372012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li X, Jiang L, Yang M, Wu YW, Sun SX and
Sun JZ: Expression of CTRP3, a novel adipokine, in rats at
different pathogenic stages of type 2 diabetes mellitus and the
impacts of GLP-1 receptor agonist on it. J Diabetes Res.
2014:3985182014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhou S, Wang G and Zhang W: Effect of
TLR4/MyD88 signaling pathway on sepsis-associated acute respiratory
distress syndrome in rats, via regulation of macrophage activation
and inflammatory response. Exp Ther Med. 15:3376–3384.
2018.PubMed/NCBI
|
|
27
|
Dankel SN, Degerud EM, Borkowski K, Fjære
E, Midtbø LK, Haugen C, Solsvik MH, Lavigne AM, Liaset B, Sagen JV,
et al: Weight cycling promotes fat gain and altered clock gene
expression in adipose tissue in C57BL/6J mice. Am J Physiol
Endocrinol Metab. 306:E210–E224. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tsai S, Clemente-Casares X, Revelo XS,
Winer S and Winer DA: Are obesity-related insulin resistance and
type 2 diabetes autoimmune diseases? Diabetes. 64:1886–1897. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Neeland IJ, Poirier P and Després JP:
Cardiovascular and metabolic heterogeneity of obesity: Clinical
challenges and implications for management. Circulation.
137:1391–1406. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Strohacker K and McFarlin BK: Influence of
obesity, physical inactivity, and weight cycling on chronic
inflammation. Front Biosci (Elite Ed). 2:98–104. 2010.PubMed/NCBI
|
|
32
|
Salinardi TC, Batra P, Roberts SB, Urban
LE, Robinson LM, Pittas AG, Lichtenstein AH, Deckersbach T,
Saltzman E and Das SK: Lifestyle intervention reduces body weight
and improves cardiometabolic risk factors in worksites. Am J Clin
Nutr. 97:667–676. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wolf RM, Steele KE, Peterson LA, Magnuson
TH, Schweitzer MA and Wong GW: Lower circulating C1q/TNF-related
protein-3 (CTRP3) levels are associated with obesity: A
cross-sectional study. PLoS One. 10:e01339552015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Catenacci VA, Pan Z, Ostendorf D, Brannon
S, Gozansky WS, Mattson MP, Martin B, MacLean PS, Melanson EL and
Donahoo Troy W: A randomized pilot study comparing zero-calorie
alternate-day fasting to daily caloric restriction in adults with
obesity. Obesity (Silver Spring). 24:1874–1883. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Madero M, Arriaga JC, Jalal D, Rivard C,
McFann K, Pérez-Méndez O, Vázquez A, Ruiz A, Lanaspa MA, Jimenez
CR, et al: The effect of two energy-restricted diets, a
low-fructose diet versus a moderate natural fructose diet, on
weight loss and metabolic syndrome parameters: A randomized
controlled trial. Metabolism. 60:1551–1559. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Kodama S, Horikawa C, Fujihara K,
Yoshizawa S, Yachi Y, Tanaka S, Ohara N, Matsunaga S, Yamada T,
Hanyu O and Sone H: Quantitative relationship between body weight
gain in adulthood and incident type 2 diabetes: A meta-analysis.
Obes Rev. 15:202–214. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mehta T, Smith DL Jr, Muhammad J and
Casazza K: Impact of weight cycling on risk of morbidity and
mortality. Obes Rev. 15:870–881. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Abraham TM, Pencina KM, Pencina MJ and Fox
CS: Trends in diabetes incidence: The framingham heart study.
Diabetes Care. 38:482–487. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mackie GM, Samocha-Bonet D and Tam CS:
Does weight cycling promote obesity and metabolic risk factors?
Obes Res Clin Pract. 11:131–139. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang Y, Yatsuya H, Li Y, Chiang C,
Hirakawa Y, Kawazoe N, Tamakoshi K, Toyoshima H and Aoyama A:
Long-term weight-change slope, weight fluctuation and risk of type
2 diabetes mellitus in middle-aged Japanese men and women: Findings
of aichi workers' cohort study. Nutr Diabetes. 7:e2522017.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Stevens VL, Jacobs EJ, Sun J, Patel AV,
McCullough ML, Teras LR and Gapstur SM: Weight cycling and
mortality in a large prospective US study. Am J Epidemiol.
175:785–792. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Anderson EK, Gutierrez DA, Kennedy A and
Hasty AH: Weight cycling increases T-cell accumulation in adipose
tissue and impairs systemic glucose tolerance. Diabetes.
62:3180–3188. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Hoevenaars FP, Keijer J, Swarts HJ,
Snaas-Alders S, Bekkenkamp-Grovenstein M and van Schothorst EM:
Effects of dietary history on energy metabolism and physiological
parameters in C57BL/6J mice. Exp Physiol. 98:1053–1062. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cappellano G, Morandi EM, Rainer J,
Grubwieser P, Heinz K, Wolfram D, Bernhard D, Lobenwein S, Pierer G
and Ploner C: Human macrophages preferentially infiltrate the
superficial adipose tissue. Int J Mol Sci. 19:E14042018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ludgero-Correia A Jr, Aguila MB,
Mandarim-de-Lacerda CA and Faria TS: Effects of high-fat diet on
plasma lipids, adiposity, and inflammatory markers in
ovariectomized C57BL/6 mice. Nutrition. 28:316–323. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Mechanick JI, Zhao S and Garvey WT: The
adipokine-cardiovascular-lifestyle network: Translation to clinical
practice. J Am Coll Cardiol. 68:1785–1803. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Fasshauer M and Blüher M: Adipokines in
health and disease. Trends Pharmacol Sci. 36:461–470. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Engin A: Adiponectin-resistance in
obesity. Adv Exp Med Biol. 960:415–441. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Achari AE and Jain SK: Adiponectin, a
therapeutic target for obesity, diabetes, and endothelial
dysfunction. Int J Mol Sci. 18:E13212017. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Khan M and Joseph F: Adipose tissue and
adipokines: The association with and application of adipokines in
obesity. Scientifica (Cairo). 2014:3285922014.PubMed/NCBI
|
|
51
|
Kopp A, Bala M, Weigert J, Büchler C,
Neumeier M, Aslanidis C, Schölmerich J and Schäffler A: Effects of
the new adiponectin paralogous protein CTRP-3 and of LPS on
cytokine release from monocytes of patients with type 2 diabetes
mellitus. Cytokine. 49:51–57. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Zand H, Morshedzadeh N and Naghashian F:
Signaling pathways linking inflammation to insulin resistance.
Diabetes Metab Syndr. 1 Suppl 11:S307–S309. 2017. View Article : Google Scholar
|
|
53
|
De Felice FG and Ferreira ST:
Inflammation, defective insulin signaling, and mitochondrial
dysfunction as common molecular denominators connecting type 2
diabetes to Alzheimer disease. Diabetes. 63:2262–2272. 2014.
View Article : Google Scholar : PubMed/NCBI
|
